UGT1A10

Across TCGA pan-cancer cohorts, UGT1A10 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated UGT1A10 data layer compared with 22 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher UGT1A10 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated UGT1A10 expression acts as an unfavorable survival marker.

BRCA, LIHC, and HNSC are the cancer types where UGT1A10 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	III,IV	0.313	0.834	.004	16	view →
LIHC	DFS	Median	All	0.094	0.555	.002	12	view →
HNSC	OS	Median	All	0.187	0.685	.039	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	OS	Median	II,III,IV	0.108	0.677	<.001	6	view →
KIRP	OS	Median	All	0.192	0.705	.015	4	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

UGT1A10–BRCA (OS)

Open the BRCA breakdown →